Medications for Seasonal Affective Disorder

37 results

  • Aplenzin

    (bupropion hydrobromide)
    Bausch Health US, LLC
    Usage: APLENZIN (bupropion hydrobromide) is indicated for the treatment of major depressive disorder (MDD) and for the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Its efficacy has been demonstrated in various controlled clinical trials.

  • Bupropion hydrochloride (bupropion hydrochloride)

    (bupropion hydrochloride)
    Bryant Ranch Prepack
    Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for the treatment of major depressive disorder (MDD) and the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy has been established through various controlled clinical trials.

  • Bupropion hydrochloride (bupropion hydrochloride)

    (bupropion hydrochloride)
    Bryant Ranch Prepack
    Usage: Bupropion hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder (MDD) and the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy was established through various controlled clinical trials.

  • Bupropion hydrochloride (bupropion hydrochloride)

    (bupropion hydrochloride)
    Biocon Pharma Inc.
    Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) and for preventing seasonal major depressive episodes in seasonal affective disorder (SAD). Efficacy was established through controlled trials for both conditions in adult patients.

  • Bupropion hydrochloride (bupropion hydrochloride)

    (Bupropion hydrochloride)
    Granules Pharmaceuticals Inc.
    Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) and preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy has been established in controlled clinical trials for both indications.

  • Bupropion hydrochloride (bupropion hydrochloride)

    (BUPROPION HYDROCHLORIDE)
    RPK Pharmaceuticals, Inc.
    Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for the treatment of major depressive disorder (MDD) and the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy has been established through controlled clinical trials.

  • Bupropion hydrochloride (bupropion hydrochloride)

    (bupropion hydrochloride)
    TruPharma LLC
    Usage: Bupropion hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder (MDD) and the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy was established through multiple controlled trials for both conditions.

  • Bupropion hydrochloride (bupropion hydrochloride)

    (Bupropion Hydrochloride)
    Asclemed USA, Inc.
    Usage: Bupropion hydrochloride extended-release tablets are indicated for treating major depressive disorder (MDD) and for preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy was established through controlled clinical trials for both indications.

  • Bupropion hydrochloride (bupropion hydrochloride)

    (Bupropion hydrochloride)
    Bryant Ranch Prepack
    Usage: Bupropion hydrochloride extended-release tablets are indicated for treating major depressive disorder (MDD) and preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy was established in multiple controlled trials for both conditions.

  • Bupropion hydrochloride (bupropion hydrochloride)

    (Bupropion Hydrochloride)
    NCS HealthCare of KY, Inc dba Vangard Labs
    Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) and preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy is supported by controlled trials for both conditions.